Navigation Links
China Pharma Holdings, Inc. to Present at the Eighth Annual Piper Jaffray China Growth Conference in New York on May 17, 2011
Date:5/13/2011

HAIKOU, China, May 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical company in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, has been invited to present at Piper Jaffray's Eighth Annual China Growth Conference in New York City on May 17, 2011. Conference details are as follows: Conference:

Piper Jaffray Eighth Annual China Growth Conference Date:

Tuesday, May 17, 2011Presentation time:3:30 p.m. ETLocation:

Le Parker Meridien118 West 57th StreetNew York, NY, 10019Mr. Waung will be available to meet with investors throughout the conference. Please contact your respective institutional sales representative for further details.

About China Pharma Holdings, Inc.China Pharma Holdings, Inc. is a rapidly growing specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across 30 provinces, municipalities and autonomous regions. The Company's wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit www.chinapharmaholdings.com .

Contact:China Pharma Holdings, Inc.

CCG Investor RelationsPhone: +86-898-6681-1730 (China)

Kalle Ahl, CFA, Account ManagerEmail: hps@chinapharmaholdings.comPhone: (646) 833-3417 (New York)Email: kalle.ahl@ccgir.comVivian Chen, Sr. Market Intelligence Exec.Phone: (646) 701-7445 (New York)Email: vivian.chen@ccgir.com
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Winner Medical to Present at Oppenheimer 5th Annual China Dragon Conference
2. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
3. China New Borun Announces First Quarter 2011 Financial Results
4. China Pharma Holdings, Inc. Reports First Quarter 2011 Financial Results
5. Reportlinker Adds Orthopedic Devices Market in the Emerging Countries (China, India, Brazil) - Presenting New Avenues for Growth and Profitability
6. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
7. China Medical Technologies to Present at Jefferies 2011 Global Healthcare Conference on June 7, 2011
8. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
9. China Sky One Medical Announces Conference Call to Discuss First Quarter 2011 Results
10. ICSE China to Offer Inaugural Conference Programme in 2011
11. Transgenomic, Inc. Presents Its Latest Technology at the BIT Life Sciences World DNA and Genome Day Conference, Dalian, China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology:
(Date:4/28/2017)... Washington, DC (PRWEB) , ... April 28, 2017 ... ... Unplanned Pregnancy (The National Campaign) announces its support for the Access to ... by Sen. Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce its ... has been in place since the RBMA was founded in 1968 with all board ... Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for Clinical ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... ... cardiac or hERG liability could substantially improve drug safety and minimize the cost ... provided for validating ion channel inhibition using cell lines and for cardiac toxicity ...
(Date:4/28/2017)... UTAH (PRWEB) , ... April 28, 2017 , ... ... Account Manager for the North East region. Côté has 20+ years of experience ... Prior to Phytomer, Côté worked with an array of high-end cosmetic brands, retail ...
Breaking Medicine News(10 mins):